FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Peter Ferenci

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
Peter Ferenci; Sandra Beinhardt
Silibinin: an old drug in the high tech era of liver transplantation.
Sandra Beinhardt; Karoline Rutter; Albert Friedrich Stättermayer; Peter Ferenci
Revisiting the predictors of a sustained virologic response in the era of direct-acting antiviral therapy for hepatitis C virus.
Harald Hofer; Peter Knoflach; Thomas Müller; Michael Trauner; Wolfgang Vogel; Claudia Willheim-Polli; Christian Gabriel; Peter Ferenci
Identification of a novel Wilson disease gene mutation frequent in Upper Austria: a genetic and clinical study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Peter Ferenci (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Peter Ferenci; Sandra Beinhardt
Silibinin: an old drug in the high tech era of liver transplantation.
Journal of hepatology 2013;58(3):409-11.
2013: Sandra Beinhardt; Karoline Rutter; Albert Friedrich Stättermayer; Peter Ferenci
Revisiting the predictors of a sustained virologic response in the era of direct-acting antiviral therapy for hepatitis C virus.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2013;56(1):118-22.
2012: Harald Hofer; Peter Knoflach; Thomas Müller; Michael Trauner; Wolfgang Vogel; Claudia Willheim-Polli; Christian Gabriel; Peter Ferenci
Identification of a novel Wilson disease gene mutation frequent in Upper Austria: a genetic and clinical study.
Journal of human genetics 2012;57(9):564-7.
2012: Albert Friedrich Stättermayer; Harald Hofer; Peter Ferenci
Association between IL28B polymorphism and treatment response in patients with genotype 4 chronic hepatitis C.
Journal of hepatology 2012;57(3):706; author reply 706-7.
2012: Vincent Rijckborst; Krzysztof Simon; Martijn J ter Borg; Anneke J van Vuuren; Elke Verhey; Ulus Akarca; Meral Akdogan; Charles A Boucher; Peter Ferenci; Robert Flisiak; Bettina E Hansen; Harry L A Janssen; Binnur Pinarbasi; Maria Raptopoulou-Gigi
Long-term follow-up of hepatitis B e antigen-negative patients treated with peginterferon α-2a: progressive decrease in hepatitis B surface antigen in responders.
European journal of gastroenterology & hepatology 2012;24(9):1012-9.
2012: Albert Friedrich Stättermayer; Petra Steindl-Munda; Michael Trauner; Fritz Wrba; Harald Hofer; Michael Krebs; Karoline Rutter; Thomas-Matthias Scherzer; Andreas Stadlmayr; Sandra Beinhardt; Christian Datz; Peter Ferenci
Association of the IL28B genotype with insulin resistance in patients with chronic hepatitis C.
Journal of hepatology 2012;57(3):492-8.
2012: Samuel S Lee; Diethelm Messinger; Stuart K Roberts; Fernando Tatsch; Edward J Gane; Stephanos J Hadziyannis; Kwang-Hyub Han; Hugh A Harley; Yves J Horsmans; Petr Husa; E Jenny Heathcote; Hanna Berak; Geoffrey M Dusheiko; Peter Ferenci
Safety of peginterferon alfa-2a plus ribavirin in a large multinational cohort of chronic hepatitis C patients.
Liver international : official journal of the International Association for the Study of the Liver 2012;32(8):1270-7.
2012: Peter Ferenci
Response guided therapy in patients with chronic hepatitis C - yesterday, today and tomorrow.
Best practice & research. Clinical gastroenterology 2012;26(4):463-9.
2012: Berit A Payer; Markus Peck-Radosavljevic; Thomas Reiberger; Armin Rieger; Judith H Aberle; Peter Ferenci; Heidemarie Holzmann
IL28B and interferon-gamma inducible protein 10 for prediction of rapid virologic response and sustained virologic response in HIV-HCV-coinfected patients.
European journal of clinical investigation 2012;42(6):599-606.
2012: Vincent Rijckborst; Fehmi Tabak; A Galeota Lanza; Benedetta Massetto; Vincenzo Messina; Loredana Regep; Maurizia R Brunetto; YILMAZ CAKALOGLU; Massimo Colombo; Peter Ferenci; Bettina E Hansen; Claudio Iannacone; Harry L A Janssen; Pietro Lampertico
Validation of a stopping rule at week 12 using HBsAg and HBV DNA for HBeAg-negative patients treated with peginterferon alfa-2a.
Journal of hepatology 2012;56(5):1006-11.
2012: Radan Bruha; Martin Haluzik; Alena Jiraskova; Ivana Malikova; Zdenek Marecek; Pavel Martasek; Sona Nevsimalova; Jaromir Petrtyl; Lenka Pospisilova; Petr Urbanek; Libor Vitek; Peter Ferenci
Decreased serum antioxidant capacity in patients with Wilson disease is associated with neurological symptoms.
Journal of inherited metabolic disease 2012;35(3):541-8.
2012: Peter Ferenci; Eve A Roberts
Defining Wilson disease phenotypes: from the patient to the bench and back again.
Gastroenterology 2012;142(4):692-6.
2012: Peter Ferenci
Optimal treatment duration for patients with HCV genotype 1 infection.
Journal of viral hepatitis 2012;19 Suppl 1():7-13.
2011: Thomas-Matthias Scherzer; Albert Friedrich Stättermayer; Rudolf Stauber; Petra Steindl-Munda; Michael Strasser; Christian Datz; Emina Dulic-Lakovic; Harald Hofer; Hermann Laferl; Andreas Maieron; Peter Ferenci
Impact of IL28B on treatment outcome in hepatitis C virus G1/4 patients receiving response-guided therapy with peginterferon alpha-2a (40KD)/ribavirin.
Hepatology (Baltimore, Md.) 2011;54(5):1518-26.
2011: Peter Ferenci
Polymorphism of methylenetetrahydrofolate reductase as disease modifier - a déjà-vu in Wilson disease?
Journal of hepatology 2011;55(4):753-5.
2011: Thomas Reiberger; Karoline Rutter; Michael Trauner; Sandra Beinhardt; Peter Ferenci; Arnulf Ferlitsch; Alfred Gangl; Harald Hofer; Michael Kundi; Berit Anna Payer; Markus Peck-Radosavljevic
Portal pressure predicts outcome and safety of antiviral therapy in cirrhotic patients with hepatitis C virus infection.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2011;9(7):602-8.e1.
2011: Peter Ferenci
Safety and efficacy of treatment for chronic hepatitis C with a focus on pegylated interferons: the backbone of therapy today and in the future.
Expert opinion on drug safety 2011;10(4):529-44.
2011: Harald Hofer; C Mueller; S Neumueller-Guber; T-M Scherzer; K Staufer; Petra Steindl-Munda; F Wrba; I Aydin; Peter Ferenci
Prevalence and clinical significance of GB virus type C/hepatitis G virus coinfection in patients with chronic hepatitis C undergoing antiviral therapy.
Journal of viral hepatitis 2011;18(7):513-7.
2011: Thomas-Matthias Scherzer; Harald Hofer; Albert Friedrich Staettermayer; Karoline Rutter; Sandra Beinhardt; Petra Steindl-Munda; Heidrun Kerschner; Harald H Kessler; Peter Ferenci
Early virologic response and IL28B polymorphisms in patients with chronic hepatitis C genotype 3 treated with peginterferon alfa-2a and ribavirin.
Journal of hepatology 2011;54(5):866-71.
2011: Albert Friedrich Stättermayer; Rudolf Stauber; Harald Hofer; Karoline Rutter; Sandra Beinhardt; Thomas Matthias Scherzer; Kerstin Zinober; Christian Datz; Andreas Maieron; Emina Dulic-Lakovic; Harald H Kessler; Petra Steindl-Munda; Michael Strasser; Christoph Krall; Peter Ferenci
Impact of IL28B genotype on the early and sustained virologic response in treatment-naïve patients with chronic hepatitis C.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2011;9(4):344-350.e2.
2011: Sandra Beinhardt; Susanne Rasoul-Rockenschaub; Thomas Matthias Scherzer; Peter Ferenci
Silibinin monotherapy prevents graft infection after orthotopic liver transplantation in a patient with chronic hepatitis C.
Journal of hepatology 2011;54(3):591-2; author reply 592-3.
2011: Andreas Maieron; Sigrid Metz-Gercek; Thomas-Matthias Scherzer; Martin Bischof; Gabriele Fischer; Michael Gschwantler; Hermann Laferl; Peter Ferenci
Shortening of treatment duration in patients with chronic hepatitis C genotype 2 and 3 - impact of ribavirin dose - a randomized multicentre trial.
BMC research notes 2011;4():220.
2010: Jennifer A Smith; Judith H Aberle; Vicki M Fleming; Peter Ferenci; Emma C Thomson; Peter Karayiannis; Angela R McLean; Heidemarie Holzmann; Paul Klenerman
Dynamic coinfection with multiple viral subtypes in acute hepatitis C.
The Journal of infectious diseases 2010;202(12):1770-9.
2010: B A Payer; T Reiberger; K Rutter; S Beinhardt; A F Staettermayer; M Peck-Radosavljevic; Peter Ferenci
Successful HCV eradication and inhibition of HIV replication by intravenous silibinin in an HIV-HCV coinfected patient.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2010;49(2):131-3.
2010: Vincent Rijckborst; Martijn J ter Borg; YILMAZ CAKALOGLU; Peter Ferenci; Fehmi Tabak; Meral Akdogan; Krzysztof Simon; Maria Raptopoulou-Gigi; Necati Ormeci; Pieter E Zondervan; Elke Verhey; Anneke J van Vuuren; Bettina E Hansen; Harry L A Janssen
A randomized trial of peginterferon alpha-2a with or without ribavirin for HBeAg-negative chronic hepatitis B.
The American journal of gastroenterology 2010;105(8):1762-9.
2010: Harald Hofer; Josef Donnerer; Kathrin Sator; Katharina Staufer; Thomas-Matthias Scherzer; Clemens Dejaco; Michael Sator; Harald Kessler; Peter Ferenci
Seminal fluid ribavirin level and functional semen parameters in patients with chronic hepatitis C on antiviral combination therapy.
Journal of hepatology 2010;52(6):812-6.
2010: Martin Krssák; Harald Hofer; Fritz Wrba; Martin Meyerspeer; Attila Brehm; Alfred Lohninger; Petra Steindl-Munda; Ewald Moser; Peter Ferenci; Michael Roden
Non-invasive assessment of hepatic fat accumulation in chronic hepatitis C by 1H magnetic resonance spectroscopy.
European journal of radiology 2010;74(3):e60-6.
2010: Monika Schmid; Markus Peck-Radosavljevic; Franz König; Christian Mittermaier; Alfred Gangl; Peter Ferenci
A double-blind, randomized, placebo-controlled trial of intravenous L-ornithine-L-aspartate on postural control in patients with cirrhosis.
Liver international : official journal of the International Association for the Study of the Liver 2010;30(4):574-82.
2010: Peter Ferenci
Hepatitis: Treatment of chronic hepatitis C-how much interferon is enough?
Nature reviews. Gastroenterology & hepatology 2010;7(4):191-3.
2010: Peter Ferenci; Michael Fried; Douglas Labrecque; Jordi Bruix; Morris Sherman; Masao Omata; Jenny Heathcote; Teehra Piratsivuth; Mike Kew; Jesse A Otegbayo; S S Zheng; S Sarin; Saeed S Hamid; Salma Barakat Modawi; Wolfgang Fleig; Suliman Fedail; Alan Thomson; Aamir Khan; Peter Malfertheiner; George Lau; Flair J Carillo; Justus Krabshuis; Anton Le Mair
Hepatocellular carcinoma (HCC): a global perspective.
Journal of clinical gastroenterology 2010;44(4):239-45.
2010: Peter Ferenci; Hermann Laferl; Thomas-Matthias Scherzer; Andreas Maieron; Harald Hofer; Rudolf Stauber; Michael Gschwantler; Harald Brunner; Christoph Wenisch; Martin Bischof; Michael Strasser; Christian Datz; Wolfgang Vogel; Karin Löschenberger; Petra Steindl-Munda
Peginterferon alfa-2a/ribavirin for 48 or 72 weeks in hepatitis C genotypes 1 and 4 patients with slow virologic response.
Gastroenterology 2010;138(2):503-12, 512.e1.
2010: Sibylle Pramhas; Monika Homoncik; Peter Ferenci; Arnulf Ferlitsch; Thomas Scherzer; Alfred Gangl; Markus Peck-Radosavljevic
von Willebrand factor antigen: a novel on-treatment predictor of response to antiviral therapy in chronic hepatitis C genotypes 1 and 4.
Antiviral therapy 2010;15(6):831-9.
2010: Uta Merle; Karl Heinz Weiss; Christoph Eisenbach; Sabine Tuma; Peter Ferenci; Wolfgang Stremmel
Truncating mutations in the Wilson disease gene ATP7B are associated with very low serum ceruloplasmin oxidase activity and an early onset of Wilson disease.
BMC gastroenterology 2010;10():8.
2009: Reinhard Kitzberger; Georg-Christian Funk; Ulrike Holzinger; Wolfgang Miehsler; Ludwig Kramer; Alexandra Kaider; Peter Ferenci; Christian Madl
Severity of organ failure is an independent predictor of intracranial hypertension in acute liver failure.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2009;7(9):1000-6.
2008: Peter Ferenci; Thomas-Matthias Scherzer; Heidrun Kerschner; Karoline Rutter; Sandra Beinhardt; Harald Hofer; Maximilian Schöniger-Hekele; Heidemarie Holzmann; Petra Steindl-Munda
Silibinin is a potent antiviral agent in patients with chronic hepatitis C not responding to pegylated interferon/ribavirin therapy.
Gastroenterology 2008;135(5):1561-7.
2008: T M Scherzer; K Staufer; Gottfried Novacek; Petra Steindl-Munda; S Schumacher; Harald Hofer; Peter Ferenci; Harald Vogelsang
Efficacy and safety of antiviral therapy in patients with Crohn's disease and chronic hepatitis C.
Alimentary pharmacology & therapeutics 2008;28(6):742-8.
2008: T-M Scherzer; K Rajender Reddy; F Wrba; Harald Hofer; K Staufer; Petra Steindl-Munda; Alfred Gangl; Peter Ferenci
Hepatocellular carcinoma in long-term sustained virological responders following antiviral combination therapy for chronic hepatitis C.
Journal of viral hepatitis 2008;15(9):659-65.
2008: Peter Ferenci; Hermann Laferl; Thomas-Matthias Scherzer; Michael Gschwantler; Andreas Maieron; Harald Brunner; Rudolf E Stauber; Martin Bischof; Bernhard Bauer; Christian Datz; Karin Löschenberger; Elisabeth Formann; Katharina Staufer; Petra Steindl-Munda
Peginterferon alfa-2a and ribavirin for 24 weeks in hepatitis C type 1 and 4 patients with rapid virological response.
Gastroenterology 2008;135(2):451-8.
2008: T Reiberger; Susanne Rasoul-Rockenschaub; Armin Rieger; Peter Ferenci; Alfred Gangl; Markus Peck-Radosavljevic
Efficacy of interferon in immunocompromised HCV patients after liver transplantation or with HIV co-infection.
European journal of clinical investigation 2008;38(6):421-9.
2008: Peter Ferenci; Harald Brunner; Hermann Laferl; Thomas-Matthias Scherzer; Andreas Maieron; Michael Strasser; Gabriele Fischer; Harald Hofer; Martin Bischof; Rudolf E Stauber; Michael Gschwantler; Petra Steindl-Munda; Katharina Staufer; Karin Löschenberger
A randomized, prospective trial of ribavirin 400 mg/day versus 800 mg/day in combination with peginterferon alfa-2a in hepatitis C virus genotypes 2 and 3.
Hepatology (Baltimore, Md.) 2008;47(6):1816-23.
2008: Peter Ferenci; Katharina Staufer
Depression in chronic hepatitis: the virus, the drug, or the ethnic background?
Liver international : official journal of the International Association for the Study of the Liver 2008;28(4):429-31.
2008: Christoph Gasche; Manuela Nemeth; Paul Grundtner; Claudia Willheim-Polli; Peter Ferenci; Robert Schwarzenbacher
Evolution of Crohn's disease-associated Nod2 mutations.
Immunogenetics 2008;60(2):115-20.
2008: Peter Ferenci
Peginterferon and ribavirin in HCV: improvement of sustained viral response.
Best practice & research. Clinical gastroenterology 2008;22(6):1109-22.
2008: Christian Müller; Maximilian Schöniger-Hekele; Rüdiger Schernthaner; Barbara Renner; Markus Peck-Radosavljevic; Andrea Brichta; Fritz Wrba; Martin Posch; Peter Bauer; Peter Ferenci; Alfred Gangl
Percutaneous ethanol instillation therapy for hepatocellular carcinoma - a randomized controlled trial.
Wiener klinische Wochenschrift 2008;120(19-20):608-18.
2008: Wolfgang Jessner; Michael Gschwantler; Elisabeth Formann; Calin Gurguta; Thomas Watkins-Riedel; Friedrich Wrba; Peter Ferenci
Very early viral kinetics on interferon treatment in chronic hepatitis C virus genotype 4 infection.
Antiviral therapy 2008;13(4):581-9.
2008: Samuel S Lee; Peter Ferenci
Optimizing outcomes in patients with hepatitis C virus genotype 1 or 4.
Antiviral therapy 2008;13 Suppl 1():9-16.
2008: Lili Kazemi-Shirazi; Moema Pinheiro Veloso; Florian Frommlet; Petra Steindl-Munda; Fritz Wrba; Sonja Zehetmayer; Claudia Marsik; Peter Ferenci
Differentiation of nonalcoholic from alcoholic steatohepatitis: are routine laboratory markers useful?
Wiener klinische Wochenschrift 2008;120(1-2):25-30.
2007: Wolfgang Jessner; Thomas Watkins-Riedel; Christian Müller; Elisabeth Formann; Michael Gschwantler; Peter Ferenci
Comparison of the Bayer VERSANT HCV RNA 3.0 and the Roche COBAS Amplicor HCV Monitor, Version 2.0, assays in HCV genotype 4 infection.
Journal of viral hepatitis 2007;14(11):775-81.
2007: Peter Ferenci; Stefan Ferenci; Christian Datz; Ingo Rezman; Wilhelm Oberaigner; Reinhild Strauss
Morbidity and mortality in paid Austrian plasma donors infected with hepatitis C at plasma donation in the 1970s.
Journal of hepatology 2007;47(1):31-6.
2007: Judith H Aberle; Gabriela Perstinger; Lukas Weseslindtner; Ursula Sinzinger; Calin Gurguta; Petra Steindl-Munda; Michael Kundi; Theresia Popow-Kraupp; Peter Ferenci; Heidemarie Holzmann
CD4+ T cell responses in patients with chronic hepatitis C undergoing peginterferon/ribavirin therapy correlate with faster, but not sustained, viral clearance.
The Journal of infectious diseases 2007;195(9):1315-9.
2007: Peter Ferenci; Anna Członkowska; Uta Merle; Szalay Ferenc; Grazyna Gromadzka; Cihan Yurdaydin; Wolfgang Vogel; Radan Bruha; Hartmut T Schmidt; Wolfgang Stremmel
Late-onset Wilson's disease.
Gastroenterology 2007;132(4):1294-8.
2006: Simon Panzer; Esther Seel; Markus Brunner; Günther F Körmöczi; Monika Schmid; Peter Ferenci; Markus Peck-Radosavljevic
Platelet autoantibodies are common in hepatitis C infection, irrespective of the presence of thrombocytopenia.
European journal of haematology 2006;77(6):513-7.
2006: Harald Hofer; Calin Gurguta; Ulrike Bergholz; Petra Steindl-Munda; Peter Ferenci
Standard interferon-alpha in combination with ribavirin for hepatitis C patients with advanced liver disease and thrombocytopenia.
Wiener klinische Wochenschrift 2006;118(19-20):595-600.
2006: Monika Homoncik; Wolfgang Sieghart; Elisabeth Formann; Monika Schmid; Peter Ferenci; Alfred Gangl; Bernd Jilma; Markus Peck-Radosavljevic
Erythropoietin treatment is associated with more severe thrombocytopenia in patients with chronic hepatitis C undergoing antiviral therapy.
The American journal of gastroenterology 2006;101(10):2275-82.
2006: Peter Ferenci
Regional distribution of mutations of the ATP7B gene in patients with Wilson disease: impact on genetic testing.
Human genetics 2006;120(2):151-9.
2006: Peter Ferenci
Pegylated interferon plus ribavirin for chronic hepatitis C: the role of combination therapy today, tomorrow and in the future.
Minerva gastroenterologica e dietologica 2006;52(2):157-74.
2006: Judith H Aberle; Elisabeth Formann; Petra Steindl-Munda; Lukas Weseslindtner; Calin Gurguta; Gabriela Perstinger; Evelyn Grilnberger; Hermann Laferl; Hans P Dienes; Theresia Popow-Kraupp; Peter Ferenci; Heidemarie Holzmann
Prospective study of viral clearance and CD4(+) T-cell response in acute hepatitis C primary infection and reinfection.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2006;36(1):24-31.
2006: Harald Hofer; C Oesterreicher; Fritz Wrba; Peter Ferenci; Edward Penner
Centrilobular necrosis in autoimmune hepatitis: a histological feature associated with acute clinical presentation.
Journal of clinical pathology 2006;59(3):246-9.
2006: Elisabeth Formann; Petra Steindl-Munda; Harald Hofer; Wolfgang Jessner; Ulrike Bergholz; Calin Gurguta; Peter Ferenci
Long-term follow-up of chronic hepatitis C patients with sustained virological response to various forms of interferon-based anti-viral therapy.
Alimentary pharmacology & therapeutics 2006;23(4):507-11.
2006: Wolfgang Sieghart; Monika Homoncik; Bernd Jilma; Elisabeth Formann; Peter Ferenci; Alfred Gangl; Markus Peck-Radosavljevic
Antiviral therapy decreases GpIIb/IIIa activation of platelets in patients with chronic hepatitis C.
Thrombosis and haemostasis 2006;95(2):260-6.
2006: Peter Ferenci; Elisabeth Formann; Hermann Laferl; Michael Gschwantler; Franz Hackl; Harald Brunner; Rainer Hubmann; Christian Datz; Rudolf E Stauber; Petra Steindl-Munda; Harald H Kessler; Anton Klingler; Alfred Gangl
Randomized, double-blind, placebo-controlled study of peginterferon alfa-2a (40KD) plus ribavirin with or without amantadine in treatment-naïve patients with chronic hepatitis C genotype 1 infection.
Journal of hepatology 2006;44(2):275-82.
2006: Calin Gurguta; Clemens Kauer; Ulrike Bergholz; Elisabeth Formann; Petra Steindl-Munda; Peter Ferenci
Tongue and skin hyperpigmentation during PEG-interferon-alpha/ribavirin therapy in dark-skinned non-Caucasian patients with chronic hepatitis C.
The American journal of gastroenterology 2006;101(1):197-8.
2005: Reinhard Kitzberger; Christian Madl; Peter Ferenci
Wilson disease.
Metabolic brain disease 2005;20(4):295-302.
2005: Ludwig Kramer; Harald Hofer; Edith Bauer; Georg Funk; Elisabeth Formann; Petra Steindl-Munda; Peter Ferenci
Relative impact of fatigue and subclinical cognitive brain dysfunction on health-related quality of life in chronic hepatitis C infection.
AIDS (London, England) 2005;19 Suppl 3():S85-92.
2005: Felix Stickel; Christoph H Osterreicher; Christian Datz; Peter Ferenci; Marco Wölfel; Wolfgang Norgauer; Michael R Kraus; Fritz Wrba; Claus Hellerbrand; Detlef Schuppan
Prediction of progression to cirrhosis by a glutathione S-transferase P1 polymorphism in subjects with hereditary hemochromatosis.
Archives of internal medicine 2005;165(16):1835-40.
2005: Edmund Cauza; Ursula Hanusch-Enserer; Martin Bischof; Marita Spak; Karam Kostner; Ayman Tammaa; Attila Dunky; Peter Ferenci
Increased C282Y heterozygosity in gestational diabetes.
Fetal diagnosis and therapy 2005;20(5):349-54.
2005: Barbara Schmidt; Gottfried Novacek; Andrea Brichta; Harald Vogelsang; Fritz Wrba; Peter Ferenci
Sonographic diagnosis of coeliac disease in a case with suspected acute liver failure.
European journal of gastroenterology & hepatology 2005;17(9):995-8.
2005: Peter Ferenci; Michael W Fried; Mitchell L Shiffman; Coleman I Smith; George Marinos; Fernando L Gonçales; Dieter Häussinger; Moisés Diago; Giampero Carosi; Daniel Dhumeaux; Antonio Craxì; Monique Chaneac; K Rajender Reddy
Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirin.
Journal of hepatology 2005;43(3):425-33.
2005: Peter Ferenci; Petra Steindl-Munda; Wolfgang Vogel; Wolfgang Jessner; Michael Gschwantler; Rudolf E Stauber; Christian Datz; Franz Hackl; Fritz Wrba; Peter Bauer; Oskar Lorenz
Diagnostic value of quantitative hepatic copper determination in patients with Wilson's Disease.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2005;3(8):811-8.
2005: Peter Ferenci
Wilson's Disease.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2005;3(8):726-33.
2005: Christoph H Osterreicher; Christian Datz; Felix Stickel; Claus Hellerbrand; Melitta Penz; Harald Hofer; Fritz Wrba; Edward Penner; Detlef Schuppan; Peter Ferenci
TGF-beta1 codon 25 gene polymorphism is associated with cirrhosis in patients with hereditary hemochromatosis.
Cytokine 2005;31(2):142-8.
2005: Peter Ferenci; Elisabeth Formann; Raffaella Romeo
Successful treatment of chronic hepatitis D with a short course of peginterferon alfa-2a.
The American journal of gastroenterology 2005;100(7):1626-7.
2005: Monika Schmid; Anna Kreil; Wolfgang Jessner; Monika Homoncik; Christian Datz; Alfred Gangl; Peter Ferenci; Markus Peck-Radosavljevic
Suppression of haematopoiesis during therapy of chronic hepatitis C with different interferon alpha mono and combination therapy regimens.
Gut 2005;54(7):1014-20.
2005: Christoph H Osterreicher; Christian Datz; Felix Stickel; Claus Hellerbrand; Melitta Penz; Harald Hofer; Fritz Wrba; Edward Penner; Detlef Schuppan; Peter Ferenci
Association of myeloperoxidase promotor polymorphism with cirrhosis in patients with hereditary hemochromatosis.
Journal of hepatology 2005;42(6):914-9.
2005: Harald Hofer; J B Neufeld; C Oesterreicher; Paul Grundtner; Fritz Wrba; Alfred Gangl; Peter Ferenci; Christoph Gasche
Bi-allelic presence of the interleukin-10 receptor 1 G330R allele is associated with cirrhosis in chronic HCV-1 infection.
Genes and immunity 2005;6(3):242-7.
2005: Andreas F P Temmel; Sonja Pabinger; Christian Quint; Petra Munda; Peter Ferenci; Thomas Hummel
Dysfunction of the liver affects the sense of smell.
Wiener klinische Wochenschrift 2005;117(1-2):26-30.
2005: Edmund Cauza; Ursula Hanusch-Enserer; Mehrdad Etemad; Marcus Köller; Karam Kostner; Petra Georg; Attila Dunky; Peter Ferenci
HFE genotyping demonstrates a significant incidence of hemochromatosis in undifferentiated arthritis.
Clinical and experimental rheumatology 2005;23(1):7-12.
2005: Monika Homoncik; Arnulf Ferlitsch; Peter Ferenci; Elisabeth Formann; Bernd Jilma; Alfred Gangl; Simon Panzer; Markus Peck-Radosavljevic
Short- and long-term effects of therapy with interferon-alpha and pegylated interferon-alpha/ribavirin on platelet plug formation and von Willebrand factor release in patients with chronic hepatitis C.
Alimentary pharmacology & therapeutics 2005;21(1):49-55.
2004: Thomas Watkins-Riedel; Peter Ferenci; Petra Steindl-Munda; Michael Gschwantler; Christian Mueller; Markus Woegerbauer
Early prediction of hepatitis C virus (HCV) infection relapse in nonresponders to primary interferon therapy by means of HCV RNA whole-blood analysis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(12):1754-60.
2004: Peter Ferenci
Pathophysiology and clinical features of Wilson disease.
Metabolic brain disease 2004;19(3-4):229-39.
2004: Bernhard Angermayr; Manfred Cejna; Franz Karnel; Michael Gschwantler; Franz König; Johann Pidlich; Helmuth Mendel; Harald Brunner; Ludwig Pichler; Peter Ferenci; Johannes Lammer; Alfred Gangl; Markus Peck-Radosavljevic
Transjugular intrahepatic portosystemic shunt in Vienna--a decade later.
Wiener klinische Wochenschrift 2004;116(17-18):608-13.
2004: Harald Hofer; Christoph H Osterreicher; Wolfgang Jessner; Melitta Penz; Petra Steindl-Munda; Fritz Wrba; Peter Ferenci
Hepatic iron concentration does not predict response to standard and pegylated-IFN/ribavirin therapy in patients with chronic hepatitis C.
Journal of hepatology 2004;40(6):1018-22.
2004: Elisabeth Formann; Rudolf E Stauber; Doris-Maria Denk; Wolfgang Jessner; Gernot Zollner; Petra Munda-Steindl; Alfred Gangl; Peter Ferenci
Sudden hearing loss in patients with chronic hepatitis C treated with pegylated interferon/ribavirin.
The American journal of gastroenterology 2004;99(5):873-7.
2004: Peter Ferenci
Review article: diagnosis and current therapy of Wilson's disease.
Alimentary pharmacology & therapeutics 2004;19(2):157-65.
2004: Peter Ferenci
Treatment of chronic viral hepatitis.
Best practice & research. Clinical gastroenterology 2004;18 Suppl():113-20.
2004: Peter Ferenci
Predictors of response to therapy for chronic hepatitis C.
Seminars in liver disease 2004;24 Suppl 2():25-31.
2004: Wolfgang Miehsler; Walter Reinisch; Lili Kazemi-Shirazi; Clemens Dejaco; Gottfried Novacek; Peter Ferenci; Friedrich Herbst; Judith Karner; Béla Téleky; Ewald Schober; Harald Vogelsang
Infliximab: lack of efficacy on perforating complications in Crohn's disease.
Inflammatory bowel diseases 2004;10(1):36-40.
2004: Peter Ferenci
Protease inhibitors for treatment of chronic hepatitis C--a new target for the magic bullet identified.
Journal of hepatology 2004;40(1):184-6.
2004: Peter Ferenci
Predicting the therapeutic response in patients with chronic hepatitis C: the role of viral kinetic studies.
The Journal of antimicrobial chemotherapy 2004;53(1):15-8.
2003: Peter Ferenci
Weight-based dosing of pegylated interferon-alpha in chronic hepatitis C: just a marketing 'gag'?
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2003;35(9):601-6.
2003: Gabriele Hinterhuber; Johannes Drach; Elisabeth Riedl; Kornelia Böhler; Peter Ferenci; Klaus Wolff; Dagmar Foedinger
Paraneoplastic pemphigus in association with hepatocellular carcinoma.
Journal of the American Academy of Dermatology 2003;49(3):538-40.
2003: Petra Steindl-Munda; Peter Ferenci; Harald Brunner; Karin Nachbaur; Christian Datz; Michael Gschwantler; Harald Hofer; Rudolf E Stauber; Franz Hackl; Wolfgang Jessner; Martha Rosenbeiger; Alfred Gangl; Wolfgang Vogel
Impact of high-dose interferon induction and ribavirin therapy in patients with chronic hepatitis C relapsing after or not responding to interferon monotherapy.
Liver international : official journal of the International Association for the Study of the Liver 2003;23(4):269-75.
2003: Elisabeth Formann; Wolfgang Jessner; L Bennett; Peter Ferenci
Twice-weekly administration of peginterferon-alpha-2b improves viral kinetics in patients with chronic hepatitis C genotype 1.
Journal of viral hepatitis 2003;10(4):271-6.
2003: Peter Ferenci; Karel Caca; Georgios Loudianos; Giorgina Mieli-Vergani; Stuart Tanner; Irmin Sternlieb; Michael L Schilsky; Diane Cox; Frieder Berr
Diagnosis and phenotypic classification of Wilson disease.
Liver international : official journal of the International Association for the Study of the Liver 2003;23(3):139-42.
2003: Bernhard Angermayr; Manfred Cejna; Franz Karnel; Michael Gschwantler; Franz Koenig; Johann Pidlich; H Mendel; L Pichler; Martina Wichlas; Anna Kreil; Monika Schmid; Arnulf Ferlitsch; E Lipinski; Harald Brunner; Johannes Lammer; Peter Ferenci; Alfred Gangl; Markus Peck-Radosavljevic
Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt.
Gut 2003;52(6):879-85.
2003: Wolfgang Jessner; Harald Vogelsang; Andreas Püspök; Peter Ferenci; Alfred Gangl; Gottfried Novacek; Astrid Bodisch; Etienne Wenzl
Plummer-Vinson syndrome associated with celiac disease and complicated by postcricoid carcinoma and carcinoma of the tongue.
The American journal of gastroenterology 2003;98(5):1208-9.
2003: Peter Ferenci
How to identify the genetic basis of gastrointestinal and liver diseases?
Gut 2003;52 Suppl 2():ii6-9.
2003: Edmund Cauza; Markus Peck-Radosavljevic; Herbert Ulrich-Pur; Christian Datz; Michael Gschwantler; Maximilian Schöniger-Hekele; Franz Hackl; Claudia Polli; Susanne Rasoul-Rockenschaub; Christian Müller; Fritz Wrba; Alfred Gangl; Peter Ferenci
Mutations of the HFE gene in patients with hepatocellular carcinoma.
The American journal of gastroenterology 2003;98(2):442-7.
2003: Wolfgang Jessner; Rudolf E Stauber; Franz Hackl; Christian Datz; Thomas Watkins-Riedel; Harald Hofer; Alfred Gangl; H Kessler; Peter Ferenci
Early viral kinetics on treatment with pegylated interferon-alpha-2a in chronic hepatitis C virus genotype 1 infection.
Journal of viral hepatitis 2003;10(1):37-42.
2003: Harald Hofer; Thomas Watkins-Riedel; Oskar Janata; Edward Penner; Heidemarie Holzmann; Petra Steindl-Munda; Alfred Gangl; Peter Ferenci
Spontaneous viral clearance in patients with acute hepatitis C can be predicted by repeated measurements of serum viral load.
Hepatology (Baltimore, Md.) 2003;37(1):60-4.
2002: Wolfgang Jessner; Thomas Watkins-Riedel; Elisabeth Formann; Petra Steindl-Munda; Peter Ferenci
Hepatitis C viral dynamics: basic concept and clinical significance.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2002;25 Suppl 3():S31-9.
2002: Walter Reinisch; Margareta Holub; Andreas Katz; Andreas M Herneth; Cornelia Lichtenberger; Maximilian Schoniger-Hekele; Thomas Waldhoer; Georg Oberhuber; Peter Ferenci; Alfred Gangl; Christian Mueller
Prospective pilot study of recombinant granulocyte-macrophage colony-stimulating factor and interferon-gamma in patients with inoperable hepatocellular carcinoma.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2002;25(6):489-99.
2002: Harald Hofer; Hans C Bankl; Fritz Wrba; Petra Steindl-Munda; Markus Peck-Radosavljevic; Christoph H Osterreicher; Christian Mueller; Alfred Gangl; Peter Ferenci
Hepatocellular fat accumulation and low serum cholesterol in patients infected with HCV-3a.
The American journal of gastroenterology 2002;97(11):2880-5.
2002: Wolfgang Jessner; Manon Der-Petrossian; Lene Christiansen; Harald Maier; Petra Steindl-Munda; Alfred Gangl; Peter Ferenci
Porphyria cutanea tarda during interferon/ribavirin therapy for chronic hepatitis C.
Hepatology (Baltimore, Md.) 2002;36(5):1301-2.
2002: Maximilian Schöniger-Hekele; Christian Müller; Jutta Ackermann; Johannes Drach; Fritz Wrba; Edward Penner; Peter Ferenci
Lack of evidence for involvement of fetal microchimerism in pathogenesis of primary biliary cirrhosis.
Digestive diseases and sciences 2002;47(9):1909-14.
2002: Ludwig Kramer; Edith Bauer; Georg Funk; Harald Hofer; Wolfgang Jessner; Petra Steindl-Munda; Fritz Wrba; Christian Madl; Alfred Gangl; Peter Ferenci
Subclinical impairment of brain function in chronic hepatitis C infection.
Journal of hepatology 2002;37(3):349-54.
2002: Maximilian Schöniger-Hekele; Christian Müller; Claudia Polli; Fritz Wrba; Edward Penner; Peter Ferenci
Liver pathology in compound heterozygous patients for hemochromatosis mutations.
Liver 2002;22(4):295-301.
2002: Markus Peck-Radosavljevic; Martina Wichlas; Monika Homoncik-Kraml; Anna Kreil; Harald Hofer; Wolfgang Jessner; Alfred Gangl; Peter Ferenci
Rapid suppression of hematopoiesis by standard or pegylated interferon-alpha.
Gastroenterology 2002;123(1):141-51.
2002: Peter Ferenci; Alan Lockwood; Kevin Mullen; Ralph E Tarter; Karin Weissenborn; Andres T Blei
Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.
Hepatology (Baltimore, Md.) 2002;35(3):716-21.
2002: Peter Ferenci; Gernot Zollner; Michael Trauner
Hepatic transport systems.
Journal of gastroenterology and hepatology 2002;17 Suppl():S105-12.
2001: Karel Caca; Peter Ferenci; Hans-Jürgen Kühn; Claudia Polli; Helmut Willgerodt; B Kunath; Wieland Hermann; Joachim Mössner; Frieder Berr
High prevalence of the H1069Q mutation in East German patients with Wilson disease: rapid detection of mutations by limited sequencing and phenotype-genotype analysis.
Journal of hepatology 2001;35(5):575-81.
2001: Peter Ferenci; Harald Brunner; K Nachbaur; Christian Datz; Michael Gschwantler; Harald Hofer; Rudolf E Stauber; Franz Hackl; Wolfgang Jessner; M Rosenbeiger; P Munda-Steindl; Karin Hegenbarth; Alfred Gangl; Wolfgang Vogel
Combination of interferon induction therapy and ribavirin in chronic hepatitis C.
Hepatology (Baltimore, Md.) 2001;34(5):1006-11.
2001: Ludwig Kramer; Alexandra Gendo; Christian Madl; K D Mullen; K Kaminski-Russ; Gere Sunder-Plassmann; A Schaffer; Edith Bauer; E Roth; Peter Ferenci
A controlled study of sorbent suspension dialysis in chronic liver disease and hepatic encephalopathy.
The International journal of artificial organs 2001;24(7):434-42.
2001: Peter Ferenci; Rudolf E Stauber; Petra Steindl-Munda; Michael Gschwantler; Peter Fickert; Christian Datz; Christian Müller; Franz Hackl; W Rainer; Thomas Watkins-Riedel; W Lin; Günter J Krejs; Alfred Gangl
Treatment of patients with chronic hepatitis C not responding to interferon with high-dose interferon alpha with or without ribavirin: final results of a prospective randomized trial. Austrian Hepatitis Study Group.
European journal of gastroenterology & hepatology 2001;13(6):699-705.
2001: Gernot Zollner; Peter Fickert; Rainer Zenz; Andrea Fuchsbichler; Conny Stumptner; Lukas Kenner; Peter Ferenci; Rudolf E Stauber; Günter J Krejs; Helmut Denk; Kurt Zatloukal; Michael Trauner
Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases.
Hepatology (Baltimore, Md.) 2001;33(3):633-46.
2001: Maximilian Schöniger-Hekele; Christian Müller; Mathilde Kutilek; C Oesterreicher; Peter Ferenci; Alfred Gangl
Hepatocellular carcinoma in Central Europe: prognostic features and survival.
Gut 2001;48(1):103-9.
2000: Josef Kletzmayr; Bruno Watschinger; Christian Müller; D Demetriou; Elisabeth Puchhammer-Stöckl; Peter Ferenci; Josef Kovarik
Twelve months of lamivudine treatment for chronic hepatitis B virus infection in renal transplant recipients.
Transplantation 2000;70(9):1404-7.
2000: Peter Ferenci; Brigitte Dragosics; W Grunt; E Hentschel; A Königsrainer; W Petritsch; H Winkler; W Munda
[Work capacity evaluation in gastrointestinal and liver diseases. Report of the 10th Continuing Education Course of the Austrian Society of Gastroenterology and Hepatology in Alpbach, 2000].
Zeitschrift für Gastroenterologie 2000;38(11):XIX-XXIV.
2000: Maximilian Schöniger-Hekele; Christian Müller; Mathilde Kutilek; C Oesterreicher; Peter Ferenci; Alfred Gangl
Hepatocellular carcinoma in Austria: aetiological and clinical characteristics at presentation.
European journal of gastroenterology & hepatology 2000;12(8):941-8.
2000: Edmund Cauza; Herbert Ulrich-Pur; Claudia Polli; Alfred Gangl; Peter Ferenci
Distribution of patients with Wilson disease carrying the H1069Q mutation in Austria.
Wiener klinische Wochenschrift 2000;112(13):576-9.
2000: Mark Schiefermeier; H Kollegger; Christian Madl; Claudia Polli; Walter Oder; Hans-Jürgen Kühn; Frieder Berr; Peter Ferenci
The impact of apolipoprotein E genotypes on age at onset of symptoms and phenotypic expression in Wilson's disease.
Brain : a journal of neurology 2000;123 Pt 3():585-90.
2000: Markus Peck-Radosavljevic; Martina Wichlas; Johannes Zacherl; Gabriele Stiegler; PJ Stohlawetz; Michael Fuchsjäger; Anna Kreil; SM Metz-Schimmerl; Simon Panzer; Rudolf Steininger; Ferdinand Mühlbacher; Peter Ferenci; Johann Pidlich; Alfred Gangl
Thrombopoietin induces rapid resolution of thrombocytopenia after orthotopic liver transplantation through increased platelet production.
Blood 2000;95(3):795-801.
2000: Ludwig Kramer; Barbara Tribl; Alexandra Gendo; Christian Zauner; B Schneider; Peter Ferenci; Christian Madl
Partial pressure of ammonia versus ammonia in hepatic encephalopathy.
Hepatology (Baltimore, Md.) 2000;31(1):30-4.
1999: Peter Ferenci; Rudolf E Stauber; Petra Steindl-Munda; Michael Gschwantler; Peter Fickert; Christian Datz; Christian Müller; Franz Hackl; W Rainer; Thomas Watkins-Riedel; W Lin
Interim analysis of a randomized controlled trial of combination of ribavirin and high dose interferon-alpha in interferon nonresponders with chronic hepatitis C.
Journal of viral hepatitis 1999;6 Suppl 1():53-8.
1999: Clemens Dejaco; Peter Ferenci; E Schober; Klaus Kaserer; Reinhold Függer; Gottfried Novacek; Alfred Gangl
Stenosis of the common bile duct due to Ormond's disease: case report and review of the literature.
Journal of hepatology 1999;31(1):156-9.
1999: Peter Ferenci
Wilson's disease.
Italian journal of gastroenterology and hepatology 1999;31(5):416-25.
1999: Gottfried Novacek; Wolfgang Miehsler; Fritz Wrba; Peter Ferenci; Edward Penner; Harald Vogelsang
Prevalence and clinical importance of hypertransaminasaemia in coeliac disease.
European journal of gastroenterology & hepatology 1999;11(3):283-8.
1999: Lili Kazemi-Shirazi; Christian Datz; T Maier-Dobersberger; Klaus Kaserer; Franz Hackl; Claudia Polli; PE Steindl; Edward Penner; Peter Ferenci
The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C.
Gastroenterology 1999;116(1):127-34.
1998: Markus Peck-Radosavljevic; Martina Wichlas; Johann Pidlich; Paul Sims; G Meng; Johannes Zacherl; S Garg; Christian Datz; Alfred Gangl; Peter Ferenci
Blunted thrombopoietin response to interferon alfa-induced thrombocytopenia during treatment for hepatitis C.
Hepatology (Baltimore, Md.) 1998;28(5):1424-9.
1998: Peter Ferenci
[Therapy of acute and chronic hepatic encephalopathy in patients with liver cirrhosis].
Zeitschrift für Gastroenterologie 1998;36(10):909-16.
1998: Christian Müller; S Pongratz; Johann Pidlich; Edward Penner; A Kaider; M Schemper; Markus Raderer; Werner Scheithauer; Peter Ferenci
Treatment of pruritus in chronic liver disease with the 5-hydroxytryptamine receptor type 3 antagonist ondansetron: a randomized, placebo-controlled, double-blind cross-over trial.
European journal of gastroenterology & hepatology 1998;10(10):865-70.
1998: K Kaserer; R Fiedler; PE Steindl; C H Müller; F Wrba; Peter Ferenci
Liver biopsy is a useful predictor of response to interferon therapy in chronic hepatitis C.
Histopathology 1998;32(5):454-61.
1998: Markus Peck-Radosavljevic; Johann Pidlich; M Bergmann; Peter Ferenci; C Seelos; Martina Wichlas; E Lipinski; M Gnant; Alfred Gangl; Ferdinand Mühlbacher
Preoperative TNM-classification is a better prognostic indicator for recurrence of hepatocellular carcinoma after liver transplantation than albumin mRNA in peripheral blood. Liver Transplant Oncology Group.
Journal of hepatology 1998;28(3):497-503.
1998: Peter Ferenci
Wilson's disease.
Clinics in liver disease 1998;2(1):31-49, v-vi.
1998: Andreas M Herneth; PE Steindl; Peter Ferenci; E Roth; H Hörtnagl
Role of tryptophan in the elevated serotonin-turnover in hepatic encephalopathy.
Journal of neural transmission (Vienna, Austria : 1996) 1998;105(8-9):975-86.
1997: Christian Datz; M R A Lalloz; Wolfgang Vogel; Ivo W Graziadei; Franz Hackl; G Vautier; D M Layton; T Maier-Dobersberger; Peter Ferenci; Edward Penner; F Sandhofer; Adrian Bomford; Bernhard Paulweber
Predominance of the HLA-H Cys282Tyr mutation in Austrian patients with genetic haemochromatosis.
Journal of hepatology 1997;27(5):773-9.
1997: Christoph Gasche; Charalampos Aslanidis; R Kain; M Exner; Thomas Helbich; Clemens Dejaco; G Schmitz; Peter Ferenci
A novel variant of lysosomal acid lipase in cholesteryl ester storage disease associated with mild phenotype and improvement on lovastatin.
Journal of hepatology 1997;27(4):744-50.
1997: Edmund Cauza; T Maier-Dobersberger; Claudia Polli; Klaus Kaserer; Ludwig Kramer; Peter Ferenci
Screening for Wilson's disease in patients with liver diseases by serum ceruloplasmin.
Journal of hepatology 1997;27(2):358-62.
1997: T Maier-Dobersberger; Peter Ferenci; Claudia Polli; P Balać; H P Dienes; Klaus Kaserer; Christian Datz; Wolfgang Vogel; Alfred Gangl
Detection of the His1069Gln mutation in Wilson disease by rapid polymerase chain reaction.
Annals of internal medicine 1997;127(1):21-6.
1997: PE Steindl; Peter Ferenci; H P Dienes; G Grimm; I Pabinger; Christian Madl; T Maier-Dobersberger; Andreas M Herneth; Brigitte Dragosics; S Meryn; Peter Knoflach; Gerhard Granditsch; Alfred Gangl
Wilson's disease in patients presenting with liver disease: a diagnostic challenge.
Gastroenterology 1997;113(1):212-8.
1997: F Pfeffel; C Oesterreicher; Edward Penner; Peter Ferenci; C Sillaber; R Fiedler; Christian Müller
Rational use of polymerase chain reaction--based detection of viral genomes in patients with serologic markers of hepatitis B or C virus infection.
Wiener klinische Wochenschrift 1997;109(1):20-4.
1996: Peter Ferenci; R Stauber; A Propst; R Fiedler; C Müller; Michael Gschwantler; K Schütze; Christian Datz; G Judmaier; Wolfgang Vogel; G J Krejs; Alfred Gangl
Dose increase augments response rate to interferon-alpha in chronic hepatitis C.
Digestive diseases and sciences 1996;41(12 Suppl):103S-108S.
1996: Peter Ferenci; T C Gilliam; J D Gitlin; S Packman; Michael L Schilsky; Ronald Sokol; I Sternlieb
An international symposium on Wilson's and Menkes' diseases.
Hepatology (Baltimore, Md.) 1996;24(4):952-8.
1996: Peter Ferenci; Andreas M Herneth; PE Steindl
Newer approaches to therapy of hepatic encephalopathy.
Seminars in liver disease 1996;16(3):329-38.
1996: C Yurdaydin; Andreas M Herneth; Andreas Püspök; PE Steindl; E Singer; Peter Ferenci
Modulation of hepatic encephalopathy in rats with thioacetamide-induced acute liver failure by serotonin antagonists.
European journal of gastroenterology & hepatology 1996;8(7):667-71.
1996: Peter Ferenci
Treatment of hepatic encephalopathy in patients with cirrhosis of the liver.
Digestive diseases (Basel, Switzerland) 1996;14 Suppl 1():40-52.
1996: Harald Vogelsang; Ahmad Hamwi; Peter Ferenci
Elevated liver isoenzymes of alkaline phosphatase and disease activity in patients with Crohn's disease.
Digestion 1996;57(1):11-5.
1995: T Maier-Dobersberger; Christine Mannhalter; S Rack; Gerhard Granditsch; Klaus Kaserer; L Korninger; PE Steindl; Alfred Gangl; Peter Ferenci
Diagnosis of Wilson's disease in an asymptomatic sibling by DNA linkage analysis.
Gastroenterology 1995;109(6):2015-8.
1995: Harald Vogelsang; Peter Ferenci; H Resch; A Kiss; Alfred Gangl
Prevention of bone mineral loss in patients with Crohn's disease by long-term oral vitamin D supplementation.
European journal of gastroenterology & hepatology 1995;7(7):609-14.
1995: Gottfried Novacek; U Plachetzky; Regina Pötzi; S Lentner; R Slavicek; Alfred Gangl; Peter Ferenci
Dental and periodontal disease in patients with cirrhosis--role of etiology of liver disease.
Journal of hepatology 1995;22(5):576-82.
1995: Harald Vogelsang; Dieter Genser; J Wyatt; Herbert Lochs; Peter Ferenci; Gerhard Granditsch; Edward Penner
Screening for celiac disease: a prospective study on the value of noninvasive tests.
The American journal of gastroenterology 1995;90(3):394-8.
1994: Christian Madl; G Grimm; Peter Ferenci; Ludwig Kramer; W Yeganehfar; W Oder; Rudolf Steininger; Christian Zauner; Klaus Ratheiser; F Stockenhuber
Serial recording of sensory evoked potentials: a noninvasive prognostic indicator in fulminant liver failure.
Hepatology (Baltimore, Md.) 1994;20(6):1487-94.
1994: Guenther G Steger; R M Mader; Harald Vogelsang; Rainer Schöfl; Herbert Lochs; Peter Ferenci
Folate absorption in Crohn's disease.
Digestion 1994;55(4):234-8.
1994: Peter Ferenci; Andreas M Herneth; Andreas Püspök; PE Steindl
Neuropharmacologic modulation of hepatic encephalopathy: experimental and clinical data.
Advances in experimental medicine and biology 1994;368():103-12.
1993: Bruno Schneeweiss; Johannes Pammer; Klaus Ratheiser; B Schneider; Christian Madl; Ludwig Kramer; A Kranz; Peter Ferenci; Wilfred Druml; G Grimm
Energy metabolism in acute hepatic failure.
Gastroenterology 1993;105(5):1515-21.
1993: Andreas Püspök; Andreas M Herneth; PE Steindl; Peter Ferenci
Hepatic encephalopathy in rats with thioacetamide-induced acute liver failure is not mediated by endogenous benzodiazepines.
Gastroenterology 1993;105(3):851-7.
1993: W Oder; L Prayer; G Grimm; Josef Spatt; Peter Ferenci; H Kollegger; B Schneider; Alfred Gangl; Lüder Deecke
Wilson's disease: evidence of subgroups derived from clinical findings and brain lesions.
Neurology 1993;43(1):120-4.
1993: Rainer Schöfl; Peter Ferenci; Harald Vogelsang; Alfred Gangl
[Effect of a lactose-free diet on irritable bowel syndrome].
Wiener klinische Wochenschrift 1993;105(12):342-5.
1993: Peter Ferenci
Historical treatment of chronic hepatitis B and chronic hepatitis C.
Gut 1993;34(2 Suppl):S69-73.
1992: Peter Ferenci; Andreas Püspök; PE Steindl
Current concepts in the pathophysiology of hepatic encephalopathy.
European journal of clinical investigation 1992;22(9):573-81.
1992: Bruno Schneeweiss; W Graninger; Peter Ferenci; Wilfred Druml; Klaus Ratheiser; G Steger; G Grimm; B Schurz; Anton N Laggner
Short-term energy balance in patients with infections: carbohydrate-based versus fat-based diets.
Metabolism: clinical and experimental 1992;41(2):125-30.
1992: G Grimm; Christian Madl; Reinhold Katzenschlager; W Oder; Peter Ferenci; Alfred Gangl
Detailed evaluation of evoked potentials in Wilson's disease.
Electroencephalography and clinical neurophysiology 1992;82(2):119-24.
1992: M Baur; U Hay; Gottfried Novacek; Christian Dittrich; Peter Ferenci
Prevalence of antibodies to hepatitis C virus in patients with hepatocellular carcinoma in Austria.
Archives of virology. Supplementum 1992;4():76-80.
1991: PE Steindl; Andreas Püspök; Wilfred Druml; Peter Ferenci
Beneficial effect of pharmacological modulation of the GABAA-benzodiazepine receptor on hepatic encephalopathy in the rat: comparison with uremic encephalopathy.
Hepatology (Baltimore, Md.) 1991;14(6):963-8.
1991: Peter Ferenci
Pathophysiology of hepatic encephalopathy.
Hepato-gastroenterology 1991;38(5):371-6.
1991: Regina Pötzi; Peter Ferenci; Alfred Gangl
Endoscopic sclerotherapy of esophageal varices during pregnancy--case report.
Zeitschrift für Gastroenterologie 1991;29(5):246-7.
1991: G Grimm; L Prayer; W Oder; Peter Ferenci; Christian Madl; Peter Knoflach; B Schneider; Herwig Imhof; Alfred Gangl
Comparison of functional and structural brain disturbances in Wilson's disease.
Neurology 1991;41(2 ( Pt 1)):272-6.
1990: G Grimm; W Oder; L Prayer; Peter Ferenci; Christian Madl
Evoked potentials in assessment and follow-up of patients with Wilson's disease.
Lancet 1990;336(8721):963-4.
1990: Bruno Schneeweiss; W Graninger; F Stockenhuber; Wilfred Druml; Peter Ferenci; Sabine Eichinger; G Grimm; A N Laggner; K Lenz
Energy metabolism in acute and chronic renal failure.
The American journal of clinical nutrition 1990;52(4):596-601.
1990: C Yurdaydin; H Hörtnagl; PE Steindl; C Zimmermann; Christian Pifl; Ernst A Singer; Erich Roth; Peter Ferenci
Increased serotoninergic and noradrenergic activity in hepatic encephalopathy in rats with thioacetamide-induced acute liver failure.
Hepatology (Baltimore, Md.) 1990;12(4 Pt 1):695-700.
1990: Bruno Schneeweiss; W Graninger; Peter Ferenci; Sabine Eichinger; G Grimm; B Schneider; A N Laggner; K Lenz; G Kleinberger
Energy metabolism in patients with acute and chronic liver disease.
Hepatology (Baltimore, Md.) 1990;11(3):387-93.
1990: Peter Ferenci; Wolfgang Vogel; H Pristautz; J Deimer; H Denk; G Judmaier; K P Maier; G J Krejs; Alfred Gangl
One-year treatment of chronic non-A, non-B hepatitis with interferon alfa-2b.
Journal of hepatology 1990;11 Suppl 1():S50-3.
1990: Peter Ferenci; G Grimm
Benzodiazepine antagonist in the treatment of human hepatic encephalopathy.
Advances in experimental medicine and biology 1990;272():255-65.
1989: Peter Ferenci; G Grimm
[Benzodiazepine antagonists in the treatment of heptic encephalopathy].
Leber, Magen, Darm 1989;19(6):322-5.
1989: Peter Ferenci; C Zimmermann; J Ebner
Cerebral glutamine metabolism: study of modulatory effects of glutamine on gamma-aminobutyric acid-ergic neurotransmission.
Metabolism: clinical and experimental 1989;38(8 Suppl 1):25-8.
1989: Harald Vogelsang; Peter Ferenci; W Woloszczuk; H Resch; CHRISTIAN HEROLD; S Frotz; Alfred Gangl
Bone disease in vitamin D-deficient patients with Crohn's disease.
Digestive diseases and sciences 1989;34(7):1094-9.
1989: Peter Ferenci; Brigitte Dragosics; H Dittrich; H Frank; L Benda; H Lochs; S Meryn; Wolfgang Base; B Schneider
Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver.
Journal of hepatology 1989;9(1):105-13.
1989: C Zimmermann; Peter Ferenci; Christian Pifl; C Yurdaydin; J Ebner; H Lassmann; Erich Roth; H Hörtnagl
Hepatic encephalopathy in thioacetamide-induced acute liver failure in rats: characterization of an improved model and study of amino acid-ergic neurotransmission.
Hepatology (Baltimore, Md.) 1989;9(4):594-601.
1989: R Schuster; Peter Ferenci; M Schmidbauer; G Lassmann; A Kiss; S Frotz; Alfred Gangl
Intestinal neuronal degeneration in a patient with chronic idiopathic intestinal pseudoobstruction.
Digestive diseases and sciences 1989;34(1):123-8.
1989: Peter Ferenci; G Grimm; S Meryn; Alfred Gangl
Successful long-term treatment of portal-systemic encephalopathy by the benzodiazepine antagonist flumazenil.
Gastroenterology 1989;96(1):240-3.
1988: G Grimm; Peter Ferenci; Reinhold Katzenschlager; Christian Madl; Bruno Schneeweiss; A N Laggner; K Lenz; Alfred Gangl
Improvement of hepatic encephalopathy treated with flumazenil.
Lancet 1988;2(8625):1392-4.
1988: Peter Ferenci; T Stehle; J Ebner; R Schmid; Dieter Häussinger
Uptake and catabolism of gamma-aminobutyric acid by the isolated perfused rat liver.
Gastroenterology 1988;95(2):402-7.
1988: Harald Vogelsang; Peter Ferenci; S Frotz; S Meryn; Alfred Gangl
Acidic colonic microclimate--possible reason for false negative hydrogen breath tests.
Gut 1988;29(1):21-6.
1988: G Grimm; Reinhold Katzenschlager; F Holzner; Peter Ferenci; Bruno Schneeweiss; A Laggner; K Lenz; Wilfred Druml; Christian Madl
Effect of flumazenil in hepatic encephalopathy.
European journal of anaesthesiology. Supplement 1988;2():147-9.
1988: Peter Ferenci; J Ebner; C Zimmermann; Ch Kikuta; Erich Roth; Dieter Häussinger
Overestimation of serum concentrations of gamma-aminobutyric acid in patients with hepatic encephalopathy by the gamma-aminobutyric acid-radioreceptor assay.
Hepatology (Baltimore, Md.) 1988;8(1):69-72.
1987: L Zieve; Peter Ferenci; David G. Rzepczynski; J Ebner; C Zimmermann
A benzodiazepine antagonist does not alter the course of hepatic encephalopathy or neural gamma-aminobutyric acid (GABA) binding.
Metabolic brain disease 1987;2(3):201-5.
1987: Peter Ferenci; L Zieve; J Ebner; C Zimmermann; David G. Rzepczynski
Postsynaptic gamma-aminobutyric acid receptors in hepatic coma following portacaval shunt and hepatic artery ligation in the rat.
Metabolic brain disease 1987;2(3):195-200.